1. Home
  2. FTFT vs TVGN Comparison

FTFT vs TVGN Comparison

Compare FTFT & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

HOLD

Current Price

$3.09

Market Cap

26.0M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

SELL

Current Price

$6.68

Market Cap

21.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
FTFT
TVGN
Founded
N/A
2020
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Business Services
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
21.3M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
FTFT
TVGN
Price
$3.09
$6.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 6.9M
5.0K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $3,829,805.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 77.46
N/A
52 Week Low
$0.55
$0.14
52 Week High
$151.68
$39.00

Technical Indicators

Market Signals
Indicator
FTFT
TVGN
Relative Strength Index (RSI) 45.30 44.77
Support Level $3.04 $6.22
Resistance Level $3.64 $7.72
Average True Range (ATR) 0.50 0.56
MACD -0.14 -0.05
Stochastic Oscillator 4.15 40.83

Price Performance

Historical Comparison
FTFT
TVGN

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the production and sale of fruit juice concentrates (including fruit purees and fruit juices), fruit beverages (including fruit juice beverages and fruit cider beverages) in the PRC. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The Company classified its business segments into Trading Commission and Consulting services, Fast-Moving Consumer Goods (FMCG), and Supply Chain Financing and Trading.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: